Shenzhen Qinglan Biotechnology

Shenzhen Qinglan Biotechnology is a clinical-stage biotechnology company specializing in the development and industrialization of dissolving microneedle (DMN) transdermal drug delivery systems. Founded by a team from the Chinese Academy of Sciences, the company has established a proprietary platform for the mass production of microneedle patches that provide painless and efficient delivery of active ingredients. Their product portfolio spans medical aesthetics, consumer skincare, and pharmaceutical applications, including treatments for diabetes and local anesthesia. Qinglan Biotech operates a GMP-compliant manufacturing facility in Shenzhen and has secured significant investment to advance its clinical pipeline. The company aims to replace traditional needle injections with user-friendly, stable, and effective microneedle technology.